MAG
AUGX

Millrace Asset Group’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Millrace Asset Group’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-298,147
Closed -$1.22M – 93
2024
Q1 		$1.22M Buy
298,147
+95,060
+47% +$425K 1.22% 46
2023
Q4 		$1.19M Sell
203,087
-135,745
-40% -$714K 1.18% 49
2023
Q3 		$1.75M Sell
338,832
-142,550
-30% -$669K 2.16% 19
2023
Q2 		$2.31M Sell
481,382
-409,676
-46% -$1.42M 2.43% 15
2023
Q1 		$1.55M Buy
891,058
+65,840
+8% +$107K 1.81% 29
2022
Q4 		$1.29M Buy
825,218
+539
+0.1% +$687 1.46% 33
2022
Q3 		$1.2M Sell
824,679
-84,813
-9% -$145K 1.51% 28
2022
Q2 		$1.64M Buy
909,492
+131,708
+17% +$305K 1.53% 31
2022
Q1 		$2.29M Buy
777,784
+85,790
+12% +$233K 1.66% 22
2021
Q4 		$2.18M Buy
+691,994
New +$2.51M 1.27% 34

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Millrace Asset Group's AUGX Position: Q2 2024 in Review

Millrace Asset Group sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 298,147 shares — an estimated $1.22M sold.

Millrace Asset Group first reported a position in AUGX in Q4 2021 and held it in 10 quarters. The position peaked at $2.31M in Q2 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Millrace Asset Group reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Millrace Asset Group sold 298,147 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $1.22M.
  • Millrace Asset Group first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Millrace Asset Group's Augmedix, Inc. Common Stock position peaked at $2.31M in Q2 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Millrace Asset Group's 13F filing for Q2 2024, filed 12 Aug 2024.